RU93043627A - PHARMACEUTICAL COMPOSITION, CONTAINING A COMPLEX OF RESIN AND POLYAMINIC DRUGS - Google Patents

PHARMACEUTICAL COMPOSITION, CONTAINING A COMPLEX OF RESIN AND POLYAMINIC DRUGS

Info

Publication number
RU93043627A
RU93043627A RU93043627/14A RU93043627A RU93043627A RU 93043627 A RU93043627 A RU 93043627A RU 93043627/14 A RU93043627/14 A RU 93043627/14A RU 93043627 A RU93043627 A RU 93043627A RU 93043627 A RU93043627 A RU 93043627A
Authority
RU
Russia
Prior art keywords
drug
resin
complex
polyaminic
drugs
Prior art date
Application number
RU93043627/14A
Other languages
Russian (ru)
Inventor
Вилльям Келлехер Джозеф
Эрл Карпанзано Энтони
Original Assignee
Ричардсон-Викс Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ричардсон-Викс Инк. filed Critical Ричардсон-Викс Инк.
Publication of RU93043627A publication Critical patent/RU93043627A/en

Links

Claims (1)

Предлагаемые фармацевтические композиции состоят из фармакологически активных полиаминовых препаратов, связанных с катионообменной смолой с образованием комплекса препарат-смола, в котором содержание лекарственного препарата выше, чем один эквивалент амина на эквивалент актионообменника. Этот комплекс препарат-смола необязательно покрыт водопроницаемым диффузионным барьерным покрытием, которое нерастворимо в желудочно-кишечных жидкостях и обеспечивает контролируемое высвобождение препарата в желудочно-кишечном тракте.The proposed pharmaceutical compositions consist of pharmacologically active polyamine preparations associated with a cation-exchange resin with the formation of a drug-resin complex, in which the content of the drug is higher than one equivalent of amine per equivalent of an actio-exchanger. This drug-resin complex is optionally coated with a permeable diffusion barrier coating that is insoluble in the gastrointestinal fluids and provides controlled release of the drug in the gastrointestinal tract.
RU93043627/14A 1990-12-21 1991-12-16 PHARMACEUTICAL COMPOSITION, CONTAINING A COMPLEX OF RESIN AND POLYAMINIC DRUGS RU93043627A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US632,290 1990-12-21

Publications (1)

Publication Number Publication Date
RU93043627A true RU93043627A (en) 1996-05-20

Family

ID=

Similar Documents

Publication Publication Date Title
DK546389A (en) PHARMACEUTICAL COMPOSITION ON UNIT DOSAGE FORM FOR PERORAL ADMINISTRATION
FR2655266B1 (en) CIMETIDINE PHARMACEUTICAL COMPOSITIONS.
DE3686936D1 (en) ENTERAL DELIVERY SYSTEM ACTIVE ON THE TARGET ORGAN.
NO175186C (en) Process for the preparation of an osmotic delivering oral delivery system containing a moderately water-soluble, pharmaceutically acceptable salt of metoprolol
CO5560580A2 (en) FORMULATIONS OF SUCRALOSE TO DISPENSE FLAVORABLE FLAVORS
US20040208931A1 (en) Fast dissolving films for oral administration of drugs
DE69710757D1 (en) PHARMACEUTICAL FORM CONTAINING MILNACIPRANE WITH DELAYED DELIVERY OF ACTIVE SUBSTANCE
RU94032150A (en) Medicinal agent exhibiting delayed release of active-acting substance
RU93004902A (en) COMPOSITION OF PROLONGED CONTROLLED SURVIVAL OF PEPTIDE MEDICINE SUBSTANCE AND METHOD OF ITS OBTAINING
DE69524609T2 (en) DELAYED RELEASE OF PEPTIDES FROM PHARMACEUTICAL COMPOSITIONS
DK0938316T3 (en) Opioid antagonist-containing galenic formulation
CA2269707A1 (en) Soluble form osmotic dose delivery system
DK1135112T3 (en) Oral formulation for gastrointestinal drug administration
DE69836207D1 (en) ORAL PHARMACEUTICAL COMPOSITIONS WITH REDUCED BITTERITY THROUGH TASTE MASKING AGENT
ATE124255T1 (en) ORAL FORMULATIONS CONTAINING POLYPEPTIDES THAT DISBAVE IN THE LARGE INTESTINE.
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
MY107811A (en) Polyamine drug-resin complexes
WO2001013898A3 (en) Pharmaceutical formulations with different release times
RU93043627A (en) PHARMACEUTICAL COMPOSITION, CONTAINING A COMPLEX OF RESIN AND POLYAMINIC DRUGS
CA2356306A1 (en) Sulfated phosphatidylinositols, their preparation and use
Henderson Recent advances in drug delivery system technology
TH57760B (en) Drug delivery into the small and large intestines using HPMC capsules.
TH12562A (en) Resin complexes - Polyamine
ES2120354A1 (en) Therapeutic device for targeting drugs at the desired section of the gastrointestinal tract, depending on the physicochemical characteristics thereof.
RU96102195A (en) MEDICINE